UIM6:XETRA:XETRA-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 494.16

Change

-0.44 (-0.09)%

Market Cap

USD 0.47B

Volume

5.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.44 (-0.85%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.14 (-0.85%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.23 (-0.83%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.23 (-0.80%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.34 (-1.36%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.28 (-0.89%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

-0.34 (-0.73%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.44 (-0.86%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.60 (-0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.11 (-0.48%)

USD 79.79B

ETFs Containing UIM6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.96% 86% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.96% 85% B 83% B
Trailing 12 Months  
Capital Gain 26.77% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.77% 81% B- 79% B-
Trailing 5 Years  
Capital Gain 89.51% 94% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.51% 94% A 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.63% 87% B+ 83% B
Dividend Return 14.80% 87% B+ 82% B
Total Return 0.17% 16% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 14.87% 37% F 49% F
Risk Adjusted Return 99.54% 96% N/A 96% N/A
Market Capitalization 0.47B 64% D 56% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.